Edwards Lifesciences (EW) Offers A Positive Risk Reward Into ACC - Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Edwards Lifesciences (NYSE: EW) | Delayed: 98.95 +3.76 (3.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $95.19 | 52 Week High | $166.87 | |||
| Open | $98.58 | 52 Week Low | $72.20 | |||
| Day High | $99.79 | P/E | 28.76 | |||
| Day Low | $96.72 | EPS | $3.44 | |||
| Volume | 1,712,623 | |||||
